Suivre
Mojtaba Akhtari, MD, FACP
Mojtaba Akhtari, MD, FACP
Loma Linda University, School of Medicine
Adresse e-mail validée de llu.edu
Titre
Citée par
Citée par
Année
Biology of breast cancer bone metastasis
M Akhtari, J Mansuri, KA Newman, TM Guise, P Seth
Cancer biology & therapy 7 (1), 3-9, 2008
2442008
Chronic myelogenous leukemia.
S O'Brien S, Abboud CN, Akhtari M, Altman J, Berman
J Natl Compr Canc Netw 10 (1), 64-110, 2012
186*2012
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ...
JAMA oncology 7 (8), 1167-1175, 2021
1692021
Management of immune cytopenias in patients with systemic lupus erythematosus—old and new
K Newman, MB Owlia, I El-Hemaidi, M Akhtari
Autoimmunity reviews 12 (7), 784-791, 2013
1362013
Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient
K Neemann, DD Eichele, PW Smith, R Bociek, M Akhtari, A Freifeld
Transplant Infectious Disease 14 (6), E161-E165, 2012
1272012
An overview and update of chronic myeloid leukemia for primary care physicians
A Granatowicz, CI Piatek, E Moschiano, I El-Hemaidi, JD Armitage, ...
Korean journal of family medicine 36 (5), 197, 2015
1012015
Neutropenia in a patient treated with ipilimumab (anti–CTLA-4 antibody)
M Akhtari, EK Waller, DL Jaye, DH Lawson, R Ibrahim, NE Papadopoulos, ...
Journal of Immunotherapy 32 (3), 322-324, 2009
1012009
Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and VIII.
MPM Peyvandi F, Tuddenham EGD, Akhtari M, Lak M
British Journal of Haematology 100 (4), 773-776, 1998
99*1998
Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
JM Li, CR Giver, Y Lu, MS Hossain, M Akhtari, EK Waller
Immunotherapy 1 (4), 599-621, 2009
962009
Autoimmune neutropenia in adults
M Akhtari, B Curtis, EK Waller
Autoimmunity reviews 9 (1), 62-66, 2009
942009
Targeting TGF beta signaling for cancer therapy
S Iyer, ZG Wang, M Akhtari, W Zhao, P Seth
Cancer biology & therapy 4 (3), 261-266, 2005
862005
Chronic myelogenous leukemia, version 1.2014
S O’Brien, JP Radich, CN Abboud, M Akhtari, JK Altman, E Berman, ...
Journal of the National Comprehensive Cancer Network 11 (11), 1327-1340, 2013
852013
Chronic myelogenous leukemia, version 1.2015
S O’Brien, JP Radich, CN Abboud, M Akhtari, JK Altman, E Berman, ...
Journal of the National Comprehensive Cancer Network 12 (11), 1590-1610, 2014
722014
Felty’s syndrome, insights and updates
MB Owlia, K Newman, M Akhtari
The open rheumatology journal 8, 129, 2014
622014
Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults
KJ Lee, V Chow, A Weissman, S Tulpule, I Aldoss, M Akhtari
Therapeutics and clinical risk management, 1301-1310, 2016
572016
Racial disparities in COVID-19 outcomes among black and white patients with cancer
J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ...
JAMA network open 5 (3), e224304-e224304, 2022
462022
Monitoring for chemotherapy-related cardiotoxicity in the form of left ventricular systolic dysfunction: a review of current recommendations
JR Stone, R Kanneganti, M Abbasi, M Akhtari
JCO Oncology Practice 17 (5), 228-236, 2021
462021
Hematologic toxicities associated with intravenous immunoglobulin therapy
A Baxley, M Akhtari
International immunopharmacology 11 (11), 1663-1667, 2011
462011
The locus for combined factor V – factor VIII deficiency (F5F8D) maps to 18q21, between D18s849 and D18s1103.
JLB M Neerman-Arbez, M Akhtari, SE Antonarakis
Am J Hum Genet 61 (11), 143-150., 1997
461997
Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus
KA Newman, M Akhtari
Autoimmunity reviews 10 (7), 432-437, 2011
422011
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20